Pharmaceuticals

LUDIPRESS LCE

Ludipress® LCE is a co-processed excipient with a composition of 94.7 – 98.3% Lactose monohydrate and 3.0 – 4.0% Povidone (Kollidon® 30). The product is obtained by wet granulation. It is supplied as white, free-flowing granules for direct compression. Benefits • Streamlines the production process, reducing complexity and effort like no other direct-tableting excipient • Completely water-soluble • Outstanding binding power • Excellent flowability and ideal particle size distribution • Produces tablets of exceptional hardness • Accelerates product development
LUDIPRESS LCE
By: BASF


Technical Description of LUDIPRESS LCE

Product:
LUDIPRESS LCE
Principal:
BASF
CAS Number:
-
Chemical/Common Name:
-
Product Number:
290057

Do you want to read more about LUDIPRESS LCE?

Full access also means:

Your personal sales representative

Product documentation

Product support

Overview of products relationships

Meaningful insights from our experts

Order placing & order tracking

Hi there, how can we help you?

LUDIPRESS LCE - BASF | IMCD Kenya